The association between ABO blood group and SARS-CoV-2 infection: A meta-analysis
This article has been Reviewed by the following groups
Listed in
- Evaluated articles (ScreenIT)
Abstract
No abstract available
Article activity feed
-
-
-
SciScore for 10.1101/2020.07.17.20155986: (What is this?)
Please note, not all rigor criteria are appropriate for all manuscripts.
Table 1: Rigor
Institutional Review Board Statement not detected. Randomization not detected. Blinding not detected. Power Analysis not detected. Sex as a biological variable not detected. Table 2: Resources
Experimental Models: Organisms/Strains Sentences Resources Primary outcome measures were Odds Ratios (ORs) for the association of testing positive for SARS-CoV-2 (infection confirmed by Polymerase Chain Reaction, PCR) and having a specific blood group (A, B, AB, or O). ABsuggested: RRID:BDSC_203)Software and Algorithms Sentences Resources To maintain the quality of the data as high as possible, we decided to include only articles indexed on MEDLINE and LitCovid. MEDLINEsuggested: (MEDLINE, RRID:SCR_002185)Data collection … SciScore for 10.1101/2020.07.17.20155986: (What is this?)
Please note, not all rigor criteria are appropriate for all manuscripts.
Table 1: Rigor
Institutional Review Board Statement not detected. Randomization not detected. Blinding not detected. Power Analysis not detected. Sex as a biological variable not detected. Table 2: Resources
Experimental Models: Organisms/Strains Sentences Resources Primary outcome measures were Odds Ratios (ORs) for the association of testing positive for SARS-CoV-2 (infection confirmed by Polymerase Chain Reaction, PCR) and having a specific blood group (A, B, AB, or O). ABsuggested: RRID:BDSC_203)Software and Algorithms Sentences Resources To maintain the quality of the data as high as possible, we decided to include only articles indexed on MEDLINE and LitCovid. MEDLINEsuggested: (MEDLINE, RRID:SCR_002185)Data collection forms (Excel spreadsheet [Microsoft Corporation, Redmond, WA]) were used by both reviewers to extract the required data from eligible studies. Excelsuggested: NoneAll statistical analyses were performed using Stata version 16 (StataCorp, 2019. Stata Statistical Software: Release 16. StataCorpsuggested: (Stata, RRID:SCR_012763)Results from OddPub: We did not detect open data. We also did not detect open code. Researchers are encouraged to share open data when possible (see Nature blog).
Results from LimitationRecognizer: We detected the following sentences addressing limitations in the study:This study has some limitations. First, we relied on the evidence and data available in the scientific literature to date, which are still preliminary. This is mainly due to the effect of the pandemic on research and publishing timing. This also influences the intrinsic quality of the studies included in the meta-analysis, which present a great variability in terms of study design and population considered. Second, we found it difficult to obtain a uniform adjustment for confounders. Third, the considerable size of the pooled control population that we reported is mainly due to data from a single study.21 Nevertheless, the size can still be deemed adequate for each study, when considered by itself. Lastly, both cases and controls populations may be deemed not adequately representative of the general population (e.g. most of included cases are hospitalized patients). This article represents, to our knowledge, the first meta-analysis to investigate the epidemiological association of ABO blood group polymorphism with SARS-CoV-2 infection. This meta-analysis provides additional evidence of the susceptibility of blood group A individuals to SARS-CoV-2 infection and the possible protective effect of blood group O. Given the theoretical level of the underlying hypotheses, further methodologically sound studies are needed to investigate the molecular and clinical mechanism at the basis of the association between ABO polymorphism and individual susceptibility to SARS-CoV-2 infection.
Results from TrialIdentifier: No clinical trial numbers were referenced.
Results from Barzooka: We did not find any issues relating to the usage of bar graphs.
Results from JetFighter: We did not find any issues relating to colormaps.
Results from rtransparent:- Thank you for including a conflict of interest statement. Authors are encouraged to include this statement when submitting to a journal.
- Thank you for including a funding statement. Authors are encouraged to include this statement when submitting to a journal.
- No protocol registration statement was detected.
-